NCT00092287 2020-04-30Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid SyndromeIpsenPhase 3 Terminated4 enrolled
NCT04065165 2020-02-05TELEFIRSTEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Withdrawn